MERSANA THERAPEUTICS

Mersana Therapeutics Chief People Officer Carla Poulson Named One of Savoy Magazine’s 2022 Most Influential Black Executives in Corporate America

22 Jul 2022 08:00:00 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

26 May 2022 08:00:01 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces FDA Grant of Orphan Drug Designation to XMT-2056 for the Treatment of Gastric Cancer

19 May 2022 07:00:00 By Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results

09 May 2022 07:00:01 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 May 2022 16:05:00 By Nasdaq GlobeNewswire

Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022

02 May 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present Preclinical Data on XMT-1660, XMT-2056 and the Immunosynthen Platform at AACR Annual Meeting

05 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

15 Mar 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

02 Mar 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

28 Feb 2022 06:00:00 By Nasdaq GlobeNewswire

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2021 Financial Results and Business Updates

22 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

03 Feb 2022 07:00:00 By Nasdaq GlobeNewswire

Mersana Therapeutics Announces 2022 Strategic Priorities and Milestones

07 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Mersana Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire

Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe

02 Dec 2021 08:00:01 By Nasdaq GlobeNewswire

Mersana Therapeutics to Participate in the Upcoming 4th Annual Evercore ISI HealthCONx Conference

23 Nov 2021 08:00:01 By Nasdaq GlobeNewswire